CDKN2A and lung carcinoma: In a study of CDKN2A in 94 colorectal cancer patients, a concordance rate of 30% was found [53], and in a study of primary lung cancer (using MSP) by Ooki et al., the concordance rate was between 20–56% in a six-gene panel [54].